Not provided
Not provided
Not provided
Not provided
Not provided
The enrollment process is too difficult to complete
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine amoxicillin is effective in the prevention of wound infection in normal labor.
When the pregnant women is admitted due to first stage of labor , the investigator will inform the patients. If the patients give consent, the patient's data will be collect in case record form. the patients will be swab at posterior fornix and around anus to collect specimen and send to microbiology lab before per vaginal examination. After the patients finish in labor, perineal wound will be swab to collect specimen and send to microbiology lab. Then the patients are randomized in two group, the first one will receive amoxicillin and the second one will receive placebo. During admission the patients will be exam by investigator every day. After the patients are discharge, the follow up will be appoint on 6 weeks later. The infant will be swab at rectum to collect specimen and send to microbiology lab when the patient's discharge day. Every specimen will be culture for bacteria and perform antimicrobial susceptibility test for amoxicillin.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Amoxicillin | Experimental | The patient will be received amoxicillin 500 mg 2 capsules orally bid pc for 5 days |
|
| Placebo | Placebo Comparator | The patient will be received placebo 2 capsules orally bid pc for 5 days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Amoxicillin | Drug | The patient will be received amoxicillin 500 mg 2 capsules orally bid pc for 5 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of perineal wound infection | Follow up perineal wound every day during admission and follow up 6 weeks after discharge | within 6 weeks after normal labor |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Vitaya Titapant, MD | Department of Obstetrics & Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculty of Medicine Siriraj Hoapital Mahidol University | Bangkok | 10700 | Thailand |
Not provided
| ID | Term |
|---|---|
| D011645 | Puerperal Infection |
| ID | Term |
|---|---|
| D011251 | Pregnancy Complications, Infectious |
| D007239 | Infections |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
| ID | Term |
|---|---|
| D000658 | Amoxicillin |
| ID | Term |
|---|---|
| D000667 | Ampicillin |
| D010400 | Penicillin G |
| D010406 | Penicillins |
| D047090 | beta-Lactams |
| D007769 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | The patient will be received placebo 2 capsules orally bid pc for 5 days |
|
|
| D000091642 | Urogenital Diseases |
| D011644 | Puerperal Disorders |
| Lactams |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D013457 | Sulfur Compounds |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |